1. Home
  2. MX vs BDSX Comparison

MX vs BDSX Comparison

Compare MX & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magnachip Semiconductor Corporation

MX

Magnachip Semiconductor Corporation

HOLD

Current Price

$3.09

Market Cap

107.6M

Sector

Technology

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$10.29

Market Cap

88.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MX
BDSX
Founded
2003
2005
Country
South Korea
United States
Employees
N/A
N/A
Industry
Semiconductors
Precision Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.6M
88.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MX
BDSX
Price
$3.09
$10.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$5.75
$32.50
AVG Volume (30 Days)
309.8K
4.2M
Earning Date
03-11-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$224,755,000.00
$80,173,000.00
Revenue This Year
N/A
$22.01
Revenue Next Year
N/A
$26.81
P/E Ratio
N/A
N/A
Revenue Growth
14.62
22.29
52 Week Low
$2.18
$3.44
52 Week High
$5.16
$21.60

Technical Indicators

Market Signals
Indicator
MX
BDSX
Relative Strength Index (RSI) 49.93 55.16
Support Level $2.78 $9.79
Resistance Level $2.98 $11.57
Average True Range (ATR) 0.13 1.47
MACD -0.03 -0.06
Stochastic Oscillator 19.79 48.51

Price Performance

Historical Comparison
MX
BDSX

About MX Magnachip Semiconductor Corporation

MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The company operates in two segments namely, Transitional Fab 3 foundry services and Standard products business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: